$115 Billion Rare Cannabinoid Leader | InMed Pharmaceuticals



Upon its acquisition of BayMedica LLC last year, InMed Pharmaceuticals Inc.(Nasdaq: INM) made the executive decision to forge …

1 Comment

  1. Often the cannabinoid industry is overlooked knowing many companies provided false promises related to #cbd. Fast forward to today and the industry has changed. So where do you sit, do you like where the industry is headed? What do you think needs to happen for it to continue to mature?

Leave a Reply

Your email address will not be published.


*